Literature DB >> 12118527

A new case of CDG-x with stereotyped dystonic hand movements and optic atrophy.

V Prietsch1, V Peters, R Hackler, R Jakobi, B Assmann, J Fang, C Körner, A Helwig-Rolig, J R Schaefer, G F Hoffmann.   

Abstract

We report the clinical findings and the diagnostic work-up of a 17-month-old girl with CDG-x. Predominant clinical signs were, besides psychomotor retardation and truncal hypotonia, stereotyped dystonic hand movements and ophthalmological abnormalities such as optic atrophy, nystagmus and strabismus. Other symptoms that are often found in patients with CDG were not present, such as seizures, microcephaly, cerebellar hypoplasia, dysmorphic features, hepatointestinal disease, coagulopathy or multiorgan involvement. Isoelectric focusing (IEF) of the patient's serum showed a marked elevation of disialotransferrin, thus confirming an IEF type 1 pattern. A generalized glycosylation defect was confirmed also by IEF of a further glycoprotein (alpha1-antitrypsin), an increased carbohydrate deficient transferrin (CDT) serum concentration and an increased CDT/transferrin ratio. All known types of CDG-I, secondary glycosylation abnormalities and variants of amino acid sequence were excluded.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12118527     DOI: 10.1023/a:1015628810892

Source DB:  PubMed          Journal:  J Inherit Metab Dis        ISSN: 0141-8955            Impact factor:   4.982


  9 in total

Review 1.  What's new in congenital disorders of glycosylation?

Authors:  J Jaeken; H Carchon
Journal:  Eur J Paediatr Neurol       Date:  2000       Impact factor: 3.140

2.  Carbohydrate-deficient glycoprotein syndrome type V: deficiency of dolichyl-P-Glc:Man9GlcNAc2-PP-dolichyl glucosyltransferase.

Authors:  C Körner; R Knauer; U Holzbach; F Hanefeld; L Lehle; K von Figura
Journal:  Proc Natl Acad Sci U S A       Date:  1998-10-27       Impact factor: 11.205

3.  Phosphomannose isomerase deficiency: a carbohydrate-deficient glycoprotein syndrome with hepatic-intestinal presentation.

Authors:  J Jaeken; G Matthijs; J M Saudubray; C Dionisi-Vici; E Bertini; P de Lonlay; H Henri; H Carchon; E Schollen; E Van Schaftingen
Journal:  Am J Hum Genet       Date:  1998-06       Impact factor: 11.025

4.  Validation by isoelectric focusing of the anion-exchange isotransferrin fractionation step involved in determination of carbohydrate-deficient transferrin by the CDTect assay.

Authors:  T Arndt; R Hackler; T O Kleine; A M Gressner
Journal:  Clin Chem       Date:  1998-01       Impact factor: 8.327

5.  Deficiency of dolichol-phosphate-mannose synthase-1 causes congenital disorder of glycosylation type Ie.

Authors:  T Imbach; B Schenk; E Schollen; P Burda; A Stutz; S Grunewald; N M Bailie; M D King; J Jaeken; G Matthijs; E G Berger; M Aebi; T Hennet
Journal:  J Clin Invest       Date:  2000-01       Impact factor: 14.808

6.  Carbohydrate deficient glycoprotein syndrome type IV: deficiency of dolichyl-P-Man:Man(5)GlcNAc(2)-PP-dolichyl mannosyltransferase.

Authors:  C Körner; R Knauer; U Stephani; T Marquardt; L Lehle; K von Figura
Journal:  EMBO J       Date:  1999-12-01       Impact factor: 11.598

7.  Carbohydrate-deficient glycoprotein syndromes become congenital disorders of glycosylation: an updated nomenclature for CDG. First International Workshop on CDGS.

Authors:  M Aebi; A Helenius; B Schenk; R Barone; A Fiumara; E G Berger; T Hennet; T Imbach; A Stutz; C Bjursell; A Uller; J G Wahlström; P Briones; E Cardo; P Clayton; B Winchester; V Cormier-Dalre; P de Lonlay; M Cuer; T Dupré; N Seta; T de Koning; L Dorland; F de Loos; L Kupers
Journal:  Glycoconj J       Date:  1999-11       Impact factor: 2.916

8.  Phosphomannomutase deficiency is a cause of carbohydrate-deficient glycoprotein syndrome type I.

Authors:  E Van Schaftingen; J Jaeken
Journal:  FEBS Lett       Date:  1995-12-27       Impact factor: 4.124

9.  Double one-dimensional electrophoresis of human serum transferrin: a new high-resolution screening method for genetically determined variation.

Authors:  K Altland; R Hackler; W Knoche
Journal:  Hum Genet       Date:  1980       Impact factor: 4.132

  9 in total
  10 in total

1.  Life with too much polyprenol: polyprenol reductase deficiency.

Authors:  J E H Gründahl; Z Guan; S Rust; J Reunert; B Müller; I Du Chesne; K Zerres; S Rudnik-Schöneborn; N Ortiz-Brüchle; M G Häusler; J Siedlecka; E Swiezewska; C R H Raetz; T Marquardt
Journal:  Mol Genet Metab       Date:  2011-12-29       Impact factor: 4.797

2.  SRD5A3-CDG: Expanding the phenotype of a congenital disorder of glycosylation with emphasis on adult onset features.

Authors:  Patricia G Wheeler; Bobby G Ng; Laura Sanford; V Reid Sutton; Dennis W Bartholomew; Matthew T Pastore; Michael J Bamshad; Martin Kircher; Kati J Buckingham; Deborah A Nickerson; Jay Shendure; Hudson H Freeze
Journal:  Am J Med Genet A       Date:  2016-08-02       Impact factor: 2.802

3.  A novel cerebello-ocular syndrome with abnormal glycosylation due to abnormalities in dolichol metabolism.

Authors:  Eva Morava; Ron A Wevers; Vincent Cantagrel; Lies H Hoefsloot; Lihadh Al-Gazali; Jeroen Schoots; Arno van Rooij; Karin Huijben; Connie M A van Ravenswaaij-Arts; Marjolein C J Jongmans; Jolanta Sykut-Cegielska; Georg F Hoffmann; Peter Bluemel; Maciej Adamowicz; Jeroen van Reeuwijk; Bobby G Ng; Jorieke E H Bergman; Hans van Bokhoven; Christian Körner; Dusica Babovic-Vuksanovic; Michel A Willemsen; Joseph G Gleeson; Ludwig Lehle; Arjan P M de Brouwer; Dirk J Lefeber
Journal:  Brain       Date:  2010-09-17       Impact factor: 13.501

4.  Komrower Lecture. Congenital disorders of glycosylation (CDG): it's all in it!

Authors:  J Jaeken
Journal:  J Inherit Metab Dis       Date:  2003       Impact factor: 4.982

5.  Phenotypic Expansion of Congenital Disorder of Glycosylation Due to SRD5A3 Null Mutation.

Authors:  Beyhan Tuysuz; Davut Pehlivan; Ahmet Özkök; Shalini Jhangiani; Cengiz Yalcinkaya; Çiğdem Aktuğlu Zeybek; Donna Marie Muzny; James R Lupski; Richard Gibbs; Jaak Jaeken
Journal:  JIMD Rep       Date:  2015-07-29

6.  Modeling a congenital disorder of glycosylation type I in C. elegans: a genome-wide RNAi screen for N-glycosylation-dependent loci.

Authors:  Weston B Struwe; Bethany L Hughes; David W Osborn; Erica D Boudreau; Kristin M D Shaw; Charles E Warren
Journal:  Glycobiology       Date:  2009-09-03       Impact factor: 4.313

7.  SRD5A3-CDG: Emerging Phenotypic Features of an Ultrarare CDG Subtype.

Authors:  Nazreen Kamarus Jaman; Preeya Rehsi; Robert H Henderson; Ulrike Löbel; Kshitij Mankad; Stephanie Grunewald
Journal:  Front Genet       Date:  2021-12-01       Impact factor: 4.599

8.  Congenital disorder of glycosylation type Ix: review of clinical spectrum and diagnostic steps.

Authors:  E Morava; H Wosik; J Kárteszi; M Guillard; M Adamowicz; J Sykut-Cegielska; K Hadzsiev; R A Wevers; D J Lefeber
Journal:  J Inherit Metab Dis       Date:  2008-05-20       Impact factor: 4.750

9.  Adult phenotype and further phenotypic variability in SRD5A3-CDG.

Authors:  Bülent Kara; Özgecan Ayhan; Gülden Gökçay; Nurdan Başboğaoğlu; Aslıhan Tolun
Journal:  BMC Med Genet       Date:  2014-01-16       Impact factor: 2.103

10.  Identification of a case of SRD5A3-congenital disorder of glycosylation (CDG1Q) by exome sequencing.

Authors:  Neerja Gupta; Gaurav Verma; Madhulika Kabra; Sunita Bijarnia-Mahay; Aparna Ganapathy
Journal:  Indian J Med Res       Date:  2018-04       Impact factor: 2.375

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.